project id: TCGA-UCEC; case submitter id: TCGA-AX-A2HG; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.9; rna integrity number: 7.0; age at index: 56; days to birth: -20771; ethnicity: hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 20771; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1163.0; figo stage: Stage IC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 582; initial weight: 150.0; oct embedded: false; preservation method: Unknown; sample id: 5e3d8501-5e81-443f-8b64-e02a0e0b3d1f; sample submitter id: TCGA-AX-A2HG-01A; portion id: 42327e89-76ea-4bc3-95c0-52824b430b03; portion submitter id: TCGA-AX-A2HG-01A-11; slide id: 1ac91f9c-428f-4f10-9e9b-1cba4364cf9b; slide submitter id: TCGA-AX-A2HG-01A-01-TSA; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 9.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;